MarketPulse

ADMA Biologics

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Boston Scientific Faces Securities Lawsuit Over False Electrophysiology Claims

Rosen Law Firm files securities class action against Boston Scientific, alleging false statements about U.S. Electrophysiology segment sustainability. Investors have until May 4 deadline to join.
CWHBSXADMAsecurities class actionlead plaintiff deadline
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Allegations

ADMA Biologics faces securities fraud investigation for alleged channel stuffing, resulting in 29.1% stock decline to $9.63 per share.
ADMAsecurities fraudstock decline